CBD
Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace

Ryan Allway May 17th, 2019 App, News, Top News Emerald’s ultra-pure SYNC 25 CBD oil fills significant need in BC’s recreational marketplace, offering a non-THC, smoke-free alternative VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has shipped 6,000 40... Read more
CBD vs. THC: Understand The Difference

For a regular user of cannabis, the chemical structure of the product that he is consuming is perhaps not much of a concern. But for lawmakers, it is very much a concern. It is centered around the two main chemical variants of the product- cannabidiol (CBD) and tetrahydrocannabinol (THC). However, it is important to point […]

The post CBD vs. THC: Understand The Difference appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
‘Distinct products, distinct plants – that’s the only way’: Part 2 of a Q&A with CV Sciences exec Doug Mackay

As the hemp industry anticipates the U.S. Food and Drug Administration’s (FDA) first public hearing to start the process of regulating hemp extracts such as CBD in food, beverages and cosmetics, among others, a former dietary supplement executive now working with San Diego-based CBD manufacturer CV Sciences offers insight... Read more
Charlotte’s Web closes CA$140 million share offering

Charlotte’s Web, a Colorado-based CBD manufacturer, said it has raised 140 million Canadian dollars ($105 million) in a share offering. The move, in which existing shareholders sold some of their shares, was part of the company’s plans to raise up to CA$500 million. The overall raise will likely be... Read more
‘Be at the table, or you’re on the plate’: Part 1 of a Q&A with CV Sciences exec Doug Mackay

For a CBD company looking to see its products sold alongside traditional supplements and functional foods, what better place to look than a longtime executive from the natural-products world? In late March, San Diego-based CBD manufacturer CV Sciences brought on Douglas Mackay, a naturopathic doctor and former senior vice... Read more
Member Blog: Five Common Misconceptions About CBD

by Charles Alovisetti, Courtney Barnes, and Corey Cox of Vicente Sederberg LLP CBD (cannabidiol) is everywhere right now. Front page articles proclaim its virtues and ubiquity. New retailers announce their intentions to sell CBD products almost every day. But a lot of the media coverage of CBD is inaccurate... Read more
Cannabis and CBD Infused Products Continue to Be Met With Open Arms for Marijuana Stocks

Although much of the attention in the cannabis market has been paid to the companies at the top who are the large producers of the raw substance, it seems as though there is a large amount of potential for the companies working to produce cannabis-infused products and products infused with CBD. These products have seen […]

The post Cannabis and CBD Infused Products Continue to Be Met With Open Arms for Marijuana Stocks appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
CBD on High Demand in Canada

There is a great shortage of Cannabis in Canada. Due to this, there is a great loss of production for CBD or Cannabidiol. It is basically manufactured and sold in a form of oil which is used for an ailment. It helps with the release of pain, anxiety, and insomnia. Many people have used it […]

The post CBD on High Demand in Canada appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Thailand Legalizes Marijuana

In a landmark decision, Thailand becomes the first country in Southeast Asia to legalize marijuana for medical use. Thai parliament voted 166-0 to amend the Narcotic Act of 1979 to allow for the medical use of both marijuana and the locally grown herbal supplement known as Kratom.   The... Read more
CBD giant CV Sciences reports $9 million loss in first quarter

(This story has been updated to provide commentary from company executives on the results.) CV Sciences, a CBD specialist based in Las Vegas, reported revenue of $14.9 million for its first quarter ended March 31, up 85% from the same period a year ago. Net loss for the quarter... Read more



( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )